Archives

Balfour Beatty: U.S. Construction Swings To £22 Million Profit From £11 Million Loss

By Amit Chowdhry ● Aug 20, 2026

Balfour Beatty's U.S. Construction business generated £22 million of underlying profit from operations in the first half of 2026, compared with an £11 million loss a year earlier, producing a £33 million earnings swing as stronger Buildings activity and reduced Civils losses changed the economics of the segment.

Bakkt Turns $9.4 Million Transchem Payment Into $107.9 Million Fair Value Position, Driving $80.8 Million Q2 Net Income

By Amit Chowdhry ● Aug 20, 2026

Bakkt reported $80.8 million of Q2 2026 net income attributable to the company, but the profit was driven primarily by a dramatic increase in the carrying value of its investment in Transchem Limited. Bakkt had paid approximately $9.4 million toward the Transchem warrant subscription, while the 47.5 million warrants were valued at $107.9 million at June 30.

ZTO: Adjusted Net Income Jumps 50% To $465 Million As Parcel Volume Reaches 10.5 Billion

By Amit Chowdhry ● Aug 20, 2026

ZTO Express reported approximately $465 million of adjusted net income in Q2 2026, an increase of 50.3% year over year, while parcel volume reached 10.5 billion shipments and the company's market share expanded to 19.9%.

Plug Power Raises 2026 Revenue Growth Guidance To 15%-16% As Electrolyzer Conversion Improves

By Amit Chowdhry ● Aug 20, 2026

Plug Power raised its full-year 2026 revenue growth guidance to 15% to 16%, citing an expanding electrolyzer pipeline, an improving conversion rate and a commercial backlog that management expects to translate into a more heavily weighted second half of the year.

Toll Brothers: Contract Value Rises 5% Even As Home Sales Revenue Falls 8%

By Amit Chowdhry ● Aug 20, 2026

Toll Brothers' fiscal Q3 2026 net signed contract value increased approximately 5% to $2.52 billion from $2.41 billion, even as home sales revenue declined about 8% to $2.65 billion from $2.88 billion, creating a divergence between current-period deliveries and forward sales activity.

Amer Sports: DTC Revenue Jumps 40% To $896.8 Million And Reaches About 55% Of Quarterly Sales

By Amit Chowdhry ● Aug 20, 2026

Amer Sports' direct-to-consumer revenue increased 39.9% year over year to $896.8 million in Q2 2026, pushing DTC to approximately 55% of total quarterly revenue as the owner of Arc'teryx, Salomon and Wilson continues expanding its directly controlled retail and e-commerce channels.

ReNew Manufacturing Generates $59 Million Of Adjusted EBITDA, Nearly 19% Of Group Total

By Amit Chowdhry ● Aug 20, 2026

ReNew Energy Global's manufacturing business generated approximately $59 million of adjusted EBITDA in Q1 FY27, representing approximately 18.6% of consolidated adjusted EBITDA of $317.6 million and highlighting the increasing importance of solar manufacturing alongside the company's renewable-power portfolio.

The Wealth Consulting Group Surpasses $12.1 Billion AUA After 27% Growth And $2.6 Billion In Advisor Recruitment

By Amit Chowdhry ● Aug 20, 2026

The Wealth Consulting Group has surpassed $12.1 billion in assets under advisement as of July 31, 2026, marking a 27% growth rate since 2025 as the hybrid RIA and wealth management platform continues expanding through advisor recruitment and acquisitions.

Sweep: Interview With Co-Founder And CEO Ido Gaver About Making Salesforce And ServiceNow AI-Ready With An Agentic Layer

By Amit Chowdhry ● Aug 20, 2026

Sweep provides an agentic layer that helps organizations understand, change, and govern complex enterprise systems by continuously mapping metadata, dependencies, permissions, automations, and integrations. Pulse 2.0 interviewed Sweep Co-Founder and CEO Ido Gaver to learn more.

Hesai: Robotics Lidar Shipments Jump 193% As Total Lidar Volume Rises 78%

By Amit Chowdhry ● Aug 20, 2026

Hesai Group shipped 142,371 Robotics lidar units in Q2 2026, up 193.4% from 48,531 units a year earlier, as demand from humanoid robots and other physical-AI applications grew substantially faster than the company's broader lidar business.

Pony AI: Robotaxi Revenue Jumps 691% While Operating Expenses Rise Just 11%

By Amit Chowdhry ● Aug 20, 2026

Pony AI's Robotaxi services revenue surged 691.2% year over year to $12.1 million in Q2 2026, while total operating expenses increased just 11.4% to $72.1 million, creating a significant divergence between commercialization growth and operating-cost expansion as the autonomous-driving company scales its fleet.

Evogene Builds Six Active Drug Collaborations While Retaining Commercial Rights To Resulting Discoveries

By Amit Chowdhry ● Aug 20, 2026

Evogene has expanded its pharmaceutical business to six active drug development collaborations, including four agreements added since the beginning of 2026, while retaining significant commercial rights to discoveries emerging from the partnered programs. The structure gives the company potential downstream economics if compounds generated through its ChemPass AI platform advance through development and eventually reach commercialization.

Amplifica Raises $26 Million Series B To Advance Injectable Hair Regrowth Therapies

By Amit Chowdhry ● Aug 20, 2026

Amplifica Holdings Group has raised an oversubscribed $26 million Series B financing to advance its pipeline of injectable therapies designed to reactivate dormant hair follicles and promote new hair growth. The financing was led by Tasso Partners, with participation from Eli Lilly and Company, principals of Scopia Capital Management and other new and existing investors.

Remepy Raises $36 Million Series A, Bringing Total Funding To $62 Million As Parkinson’s Hybrid Drug Heads Toward Phase III

By Amit Chowdhry ● Aug 20, 2026

Remepy has raised $36 million in Series A financing to advance its pipeline of Hybrid Drugs, including global Phase III development of Hybridopa for Parkinson's disease, bringing the company's total capital raised to $62 million. The round was led by O.G. Venture Partners and M Ventures, the corporate strategic venture arm of Merck KGaA, Darmstadt, Germany.

Skan AI Raises $63 Million As Platform Grows 300%+ And Processes 25 Billion Work Signals

By Amit Chowdhry ● Aug 20, 2026

Skan AI has raised $63 million as the enterprise AI company expands a platform that gives AI agents operational context based on how employees and business processes actually work.

Bridge To Life Raises $110 Million To Scale FDA-Cleared VitaSmart Liver Perfusion System And Expand Organ Transplant Pipeline

By Amit Chowdhry ● Aug 20, 2026

Bridge to Life has completed $110 million in Series C equity and debt financing to accelerate the U.S. commercialization of its VitaSmart Hypothermic Oxygenated Perfusion System and advance a broader pipeline of organ preservation and viability technologies.

Tims China: Loyalty Membership Jumps 42% To 37.1 Million

By Amit Chowdhry ● Aug 20, 2026

Tims China's registered loyalty-club membership increased 41.7% year over year to 37.1 million members at June 30, 2026, giving the Tim Hortons China operator a substantially larger addressable customer base even as Q2 sales and transaction volumes declined.

Elauwit: Recurring Revenue Jumps 82% As Billed Units Surge To 22,967

By Amit Chowdhry ● Aug 20, 2026

Elauwit Connection's Q2 2026 recurring service revenue increased 81.8% to $1.2 million from approximately $700,000, even as total quarterly revenue declined sharply because of lower project-based network construction activity.

Einride Targets 1,500-2,000 Trucks By 2028 As Potential Long-Term ARR Pipeline Reaches $800 Million

By Amit Chowdhry ● Aug 20, 2026

Einride is targeting a fleet of approximately 1,500 to 2,000 operating trucks by 2028, supported by roughly $800 million of potential long-term annual recurring revenue under Joint Business Plans as the autonomous and electric freight company works toward cash-flow breakeven.

Prenetics: IM8 July Revenue Hits $20.9 Million, Reaching $251 Million Annualized Run Rate Just 20 Months After Launch

By Amit Chowdhry ● Aug 20, 2026

Prenetics' IM8 wellness brand generated a record $20.9 million of revenue in July 2026, equivalent to an approximately $251 million annualized revenue run rate just 20 months after the brand's launch.

Auna: Free Cash Flow Jumps 181% As Leverage Falls To 3.6x

By Amit Chowdhry ● Aug 20, 2026

Auna increased free cash flow by 181% year over year in Q2 2026 while reducing its leverage ratio to 3.6x, as improved collections and working-capital management strengthened cash generation despite lower adjusted EBITDA margins.

iQIYI Generates RMB319.6 Million Of Free Cash Flow Despite RMB287.5 Million Q2 Net Loss

By Amit Chowdhry ● Aug 20, 2026

iQIYI generated RMB319.6 million, or approximately $47.1 million, of free cash flow in Q2 2026 despite reporting a RMB287.5 million net loss attributable to the company, creating a sharp divergence between reported earnings and cash generation.

La-Z-Boy: Retail Written Sales Jump 16% As New And Acquired Stores Drive Growth

By Amit Chowdhry ● Aug 20, 2026

La-Z-Boy's Retail segment posted 16% growth in written sales during its fiscal 2027 first quarter, as acquisitions, new store openings and positive same-store sales helped offset weaker results in the company's Wholesale and Joybird businesses.

VNET: Wholesale Data Center Revenue Jumps 29% As Capacity In Service Reaches 1,007MW

By Amit Chowdhry ● Aug 20, 2026

VNET Group's wholesale data center business continued to grow as a larger driver of the company in Q2 2026, with wholesale revenue up 29.3% year over year to RMB1.10 billion, or approximately $162.8 million, as wholesale capacity in service expanded 49.4% to 1,007MW from 674MW.

RockRose Risk Raises $12.5 Million Series A To Build Vertically Integrated Wildfire Insurance And Mitigation Platform

By Amit Chowdhry ● Aug 20, 2026

RockRose Risk has raised $12.5 million in Series A financing to expand its wildfire-focused insurance platform and evolve from a technology-enabled brokerage into a vertically integrated risk management business. The round was co-led by Crosslink Capital and Congruent Ventures, with participation from Nuveen Real Estate, which has more than $136 billion in commercial real estate holdings.

Ours Privacy Raises $15 Million Series A To Scale HIPAA-Compliant Healthcare Marketing Platform Across 200+ Organizations

By Amit Chowdhry ● Aug 20, 2026

Ours Privacy has raised $15 million in Series A funding to expand its privacy-first growth marketing and data infrastructure platform for healthcare organizations. The multiple-times-oversubscribed round was led by Lightbank and Health Velocity Capital, with participation from existing investors including Rock Health, Lakehouse, TMV, Switch Ventures, Starfire Ventures and GreyMatter.

Greenstone Biosciences Wins Breakthrough T1D Grant To Build Patient-Derived 3D Islet Platform With Multi-Omics

By Amit Chowdhry ● Aug 20, 2026

Greenstone Biosciences has received a Breakthrough T1D Industry Discovery and Development Partnership grant to develop a patient-derived islet cell platform aimed at improving understanding of insulin-producing beta cells in people with type 1 diabetes.

KaliVir Immunotherapeutics Raises $14 Million Series A Extension, Bringing Total Series A Funding To $25 Million

By Amit Chowdhry ● Aug 20, 2026

KaliVir Immunotherapeutics has raised a $14 million extension of its Series A financing to support continued clinical development of VET3-TGI, its lead oncolytic immunotherapy candidate for advanced solid tumors. The financing was led by Company K Partners, with participation from SV Investment and Flexus Partners. Existing investors, including affiliates of Nextrans and Quad Investment Management, also participated. The extension brings KaliVir's total Series A financing to $25 million.

Network Bio Launches With $50 Million Financing And $30+ Million AI Partnership To Build Disease-Specific Models

By Amit Chowdhry ● Aug 20, 2026

Network Bio has launched with $50 million in financing to build disease-specific artificial intelligence models trained on large-scale human tissue, blood, molecular and clinical datasets, as the biotechnology company seeks to apply AI to diagnostics, biomarker discovery and drug development. Investors include Section 32, Thiel Bio, Founders Fund, Breyer Capital, Blue Venture Fund, JSL Health Capital and other life sciences and AI-focused funds.

Why Goldman Sachs Is Buying NEOS Investments For Up To $2.25 Billion

By Amit Chowdhry ● Aug 20, 2026

Goldman Sachs has agreed to acquire NEOS Investments for consideration of up to $2.25 billion in cash and equity, expanding Goldman Sachs Asset Management's options-based ETF capabilities and creating a combined platform with approximately $80 billion in active ETFs.